Atorlip-ez ezetimibe , administered in combination with a 3-hydroxy-3-methylglutaryl-coenzyme a hmg-coa reductase inhibitor statin , is indicated as adjunctive therapy to diet for the reduction of elevated total-c, ldl-c, and apo b in patients with primary heterozygous familial and non-familial hyperlipidemia.